| For: | Fujita KI, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol 2015; 21(43): 12234-12248 [PMID: 26604633 DOI: 10.3748/wjg.v21.i43.12234] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i43/12234.htm |
| Number | Citing Articles |
| 1 |
Peng Zhu, Zhi Ye, Dong Guo, Zongping Xiong, Shiqiong Huang, Jun Guo, Wei Zhang, James E. Polli, Honghao Zhou, Qing Li, Yan Shu. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2). Pharmaceutical Research 2018; 35(12) doi: 10.1007/s11095-018-2526-y
|
| 2 |
A.L. Zakharenko, O.A. Luzina, D.N. Sokolov, V.I. Kaledin, V.P. Nikolin, N.A. Popova, J. Patel, O.D. Zakharova, A.A. Chepanova, A. Zafar, J. Reynisson, E. Leung, I.K.H. Leung, K.P. Volcho, N.F. Salakhutdinov, O.I. Lavrik. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. European Journal of Medicinal Chemistry 2019; 161 doi: 10.1016/j.ejmech.2018.10.055
|
| 3 |
Mônica F. Quintanilha, Vivian C. Miranda, Ramon O. Souza, Bruno Gallotti, Clênio Cruz, Elandia A. Santos, Jacqueline I. Alvarez-Leite, Luís C.L. Jesus, Vasco Azevedo, Luísa M. Trindade, Valbert N. Cardoso, Enio Ferreira, Bárbara A. Carvalho, Pedro M.G. Soares, Angélica T. Vieira, Jacques R. Nicoli, Flaviano S. Martins. Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. Life Sciences 2022; 289 doi: 10.1016/j.lfs.2021.120243
|
| 4 |
Trevor Ostlund, Faez Alotaibi, Jennifer Kyeremateng, Hossam Halaweish, Abigail Kasten, Surtaj Iram, Fathi Halaweish. Triazole-estradiol analogs: A potential cancer therapeutic targeting ovarian and colorectal cancer. Steroids 2022; 177 doi: 10.1016/j.steroids.2021.108950
|
| 5 |
Izabela Rumienczyk, Maria Kulecka, Małgorzata Statkiewicz, Jerzy Ostrowski, Michal Mikula. Oncology Drug Repurposing for Sepsis Treatment. Biomedicines 2022; 10(4) doi: 10.3390/biomedicines10040921
|
| 6 |
Haniye Rahimi Kolour, Nastaran Bahrami, Ehsan Nazemalhosseini-Mojarad, Amir Sadeghi, Mehdi Shamsara, Nayeralsadat Fatemi. Metformin’s multifaceted role in colorectal cancer: mechanisms of action and synergy with standard treatments. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03905-1
|
| 7 |
Mohammed Hadi Ali Al-Jumaili, Ekhlas Aziz Bakr, Mohanad A. Huessien, Ahmed Solaiman Hamed, Mohammed J. Muhaidi. Development of heterocyclic-based anticancer agents: A comprehensive review. Heterocyclic Communications 2025; 31(1) doi: 10.1515/hc-2022-0179
|
| 8 |
Stefanie Ho Yi Chan, Raymond W. Fitzpatrick, Deborah Layton, Sherael Webley, Sam Salek. Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database. Cancers 2025; 17(2) doi: 10.3390/cancers17020311
|
| 9 |
Qiongna Dong, Bizhi Shi, Min Zhou, Huiping Gao, Xiaoying Luo, Zonghai Li, Hua Jiang. Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12. Frontiers of Medicine 2019; 13(1) doi: 10.1007/s11684-019-0682-z
|
| 10 |
Ram P. Das, Sarjak Chakravarti, Snehal S. Patel, Pooja Lakhamje, Murari Gurjar, Vikram Gota, Beena G. Singh, Amit Kunwar. Tuning the pharmacokinetics and efficacy of irinotecan (IRI) loaded gelatin nanoparticles through folate conjugation. International Journal of Pharmaceutics 2020; 586 doi: 10.1016/j.ijpharm.2020.119522
|
| 11 |
Rossella Salemi, Silvia Vivarelli, Daria Ricci, Marina Scillato, Maria Santagati, Giuseppe Gattuso, Luca Falzone, Massimo Libra. Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04036-3
|
| 12 |
Dalong Wang, Tingting Zhao, Shan Zhao, Jing Chen, Tongyi Dou, Guangbo Ge, Changyuan Wang, Huijun Sun, Kexin Liu, Qiang Meng, Jingjing Wu. Substrate-dependent Inhibition of Hypericin on Human Carboxylesterase 2: Implications
for Herb-drug Combination. Current Drug Metabolism 2022; 23(1) doi: 10.2174/1389200223666220202093303
|
| 13 |
Brandon N. VanderVeen, Thomas D. Cardaci, Brooke M. Bullard, Christian A. Unger, Jeffrey C. Freeman, Reilly T. Enos, Michael Shtutman, Michael D. Wyatt, Daping Fan, E. Angela Murphy. The impact of diet-induced obesity on 5 fluorouracil-induced tumor and liver immune cell cytotoxicity. American Journal of Physiology-Cell Physiology 2025; 328(1) doi: 10.1152/ajpcell.00687.2024
|
| 14 |
Santosh Kumar, Michael Y. Sherman. Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us. International Journal of Molecular Sciences 2023; 24(8) doi: 10.3390/ijms24087233
|
| 15 |
Erika Cecchin, Elena De Mattia, Fabrizio Ecca, Giuseppe Toffoli. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Drug Resistance Updates 2018; 39 doi: 10.1016/j.drup.2018.07.001
|
| 16 |
Eman E. Nasr, Amany S. Mostafa, Magda A. A. El‐Sayed, Mohammed A. M. Massoud. Design, synthesis, and docking study of new quinoline derivatives as antitumor agents. Archiv der Pharmazie 2019; 352(7) doi: 10.1002/ardp.201800355
|
| 17 |
E. Samalin, L. Evesque, A. Turpin, C. De La Fouchardiere, F. Khemissa-Akouz, O. Bouché, M. Muller, S. Dermeche, D. Botsen, D. Tougeron, A. Zaanan, M. Ben Abdelghani, E. Guardiola, O. Dubreuil, V. Le Brun Ly, A. Hennequin, S. Watson, D. Sefrioui, T. Lecomte, N. De Sousa Carvalho, A. Hulin, E. Crapez, F. Castan, H. Senellart. Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58–UCGI35–REGIRI Unicancer randomised phase II study. ESMO Open 2025; 10(5) doi: 10.1016/j.esmoop.2025.105096
|
| 18 |
Zuzanna Kobus, Anita Karimi, Hooman Yarmohammadi. Transarterial Therapy for Liver Tumors. Hematology/Oncology Clinics of North America 2026; 40(4) doi: 10.1016/j.hoc.2026.05.007
|
| 19 |
Benedikt Seligmann, Shenyu Liu, Mai Huynh, Thu-Thuy T. Dang, Jakob Franke. Production of the anticancer drug intermediate strictosidinic acid in engineered yeast. Journal of Biotechnology 2026; 415 doi: 10.1016/j.jbiotec.2026.03.017
|
| 20 |
Karishma Kailass, Alexandra F. Tassielli, Ruifan Dai, Francisca Beato, Bhaswati Sarcar, Jennifer Permuth, Margaret Park, Jason B. Fleming, Andrew A. Beharry. Ratiometric Fluorescent Chemosensing for Predicting Response to Irinotecan-Based Therapies in Pancreatic Ductal Adenocarcinoma. ACS Sensors 2026; 11(5) doi: 10.1021/acssensors.5c04552
|
| 21 |
Dylan T. Marsh, Scott D. Smid. Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro. Toxicology in Vitro 2024; 99 doi: 10.1016/j.tiv.2024.105888
|
| 22 |
Shuqin Xing, Yafei Wang, Kaiwen Hu, Fen Wang, Tao Sun, Quanwang Li. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11. Bioscience Reports 2020; 40(9) doi: 10.1042/BSR20200935
|
| 23 |
Nikolaos Tsakiris, Malamatenia Papavasileiou, Elia Bozzato, Alessandra Lopes, Arnaud M. Vigneron, Véronique Préat. Combinational drug-loaded lipid nanocapsules for the treatment of cancer. International Journal of Pharmaceutics 2019; 569 doi: 10.1016/j.ijpharm.2019.118588
|
| 24 |
Thaise Boeing, Priscila de Souza, Silvia Speca, Lincon Bordignon Somensi, Luisa Nathália Bolda Mariano, Benhur Judah Cury, Mariana Ferreira dos Anjos, Nara Lins Meira Quintão, Laurent Dubuqoy, Pierre Desreumax, Luisa Mota da Silva, Sérgio Faloni de Andrade. Luteolin prevents irinotecan‐induced intestinal mucositis in mice through antioxidant and anti‐inflammatory properties. British Journal of Pharmacology 2020; 177(10) doi: 10.1111/bph.14987
|
| 25 |
Anne Kauffels, Hannah Nowack, Hanibal Bohnenberger, Melanie Spitzner, Thilo Sprenger, Michael Ghadimi, Jens Sperling. Hepatic arterial infusion with nanoliposomal irinotecan leads to significant regression of tumor size of colorectal liver metastases in a CC531 rat model. Clinical & Experimental Metastasis 2023; 40(3) doi: 10.1007/s10585-023-10209-7
|
| 26 |
Neetu Saini, Monika Kadian, Anil Kumar. Biomarkers in Cancer Detection and Monitoring of Therapeutics. 2024; doi: 10.1016/B978-0-323-95116-6.00006-2
|
| 27 |
Karishma Kailass, Oleg Sadovski, Warren R. Zipfel, Andrew A. Beharry. Two-Photon Photodynamic Therapy Targeting Cancers with Low Carboxylesterase 2 Activity Guided by Ratiometric Fluorescence. Journal of Medicinal Chemistry 2022; 65(13) doi: 10.1021/acs.jmedchem.1c01965
|
| 28 |
Prasanna Anjaneyulu Yakkala, Naveen Reddy Penumallu, Syed Shafi, Ahmed Kamal. Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents. Pharmaceuticals 2023; 16(10) doi: 10.3390/ph16101456
|
| 29 |
Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, Norihiko Sugisawa, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman. Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model. Biochemical and Biophysical Research Communications 2019; 513(2) doi: 10.1016/j.bbrc.2019.03.191
|
| 30 |
Saurav Kumar Mishra, Tabsum Chhetri, Sneha Roy, Aamal A. Al-Mutairi, Adino Asmare Aragaw, Emad Rashad Sindi, Magdi E. A. Zaki, John J. Georrge. Decoding cross-talk between Mpox and HIV: insights from transcriptomics and network-based analyses. Virology Journal 2025; 23(1) doi: 10.1186/s12985-025-03026-9
|
| 31 |
Iera Hernandez-Unzueta, Aitor Benedicto, Elvira Olaso, Eduardo Sanz, Cristina Viera, Beatriz Arteta, Joana Márquez. Ocoxin oral solution® as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver. Oncology Letters 2017; 13(6) doi: 10.3892/ol.2017.6016
|
| 32 |
Jiali Dai, Yuetong Chen, Yang Gong, Jingsun Wei, Xiaowen Cui, Hualin Yu, Wenjing Zhao, Dongying Gu, Jinfei Chen. The efficacy and safety of irinotecan ± bevacizumab compared with oxaliplatin ± bevacizumab for metastatic colorectal cancer. Medicine 2019; 98(39) doi: 10.1097/MD.0000000000017384
|
| 33 |
Muttiah Barathan, Ahmad Khusairy Zulpa, Sook Luan Ng, Yogeswaran Lokanathan, Min Hwei Ng, Jia Xian Law. Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytochemicals and Extracellular Vesicles. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25137470
|
| 34 |
Justin C. Merritt, Stephen D. Richbart, Emily G. Moles, Ashley J. Cox, Kathleen C. Brown, Sarah L. Miles, Paul T. Finch, Joshua A. Hess, Maria T. Tirona, Monica A. Valentovic, Piyali Dasgupta. Anti-cancer activity of sustained release capsaicin formulations. Pharmacology & Therapeutics 2022; 238 doi: 10.1016/j.pharmthera.2022.108177
|
| 35 |
Chonghui Liu, Yan Zhang, Yingjian Liang, Tianjiao Zhang, Guohua Wang. DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer. Briefings in Bioinformatics 2024; 25(6) doi: 10.1093/bib/bbae490
|
| 36 |
Enpeng Xi, Yue Zhao, Huan Wang, Yun Zhao, Fangfang Cao, Yue Li, Nan Gao. Customized porous aromatic frameworks (PAFs) as an oral antidote for efficient and selective intestinal detoxification. Nanoscale Horizons 2026; 11(6) doi: 10.1039/D5NH00784D
|
| 37 |
Elena De Mattia, Erika Cecchin, Marcella Montico, Adrien Labriet, Chantal Guillemette, Eva Dreussi, Rossana Roncato, Alessia Bignucolo, Angela Buonadonna, Mario D’Andrea, Luigi Coppola, Sara Lonardi, Eric Lévesque, Derek Jonker, Félix Couture, Giuseppe Toffoli. Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00367
|
| 38 |
Vinod K. Nelson, Mohana Vamsi Nuli, Juturu Mastanaiah, Mohamed Saleem T. S., Geetha Birudala, Yahya F. Jamous, Omar Alshargi, Kranthi Kumar Kotha, Hari Hara Sudhan, Ravishankar Ram Mani, Alagusundaram Muthumanickam, Divya Niranjan, Nem Kumar Jain, Ankur Agrawal, Arvind Singh Jadon, Vinyas Mayasa, Niraj Kumar Jha, Adriana Kolesarova, Petr Slama, Shubhadeep Roychoudhury. Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1201198
|
| 39 |
Yifeng Qin, An Kang, Guisheng Zhou, Huan Wang, Wei Wei, Yujie Cao, Yanyan Chen, Jing Wang, Yajun Shi, Yuping Tang, Jianqin Jiang. Carboxylesterase and UDP‐glucuronosyltransferases mediated metabolism of irinotecan: In vitro and in vivo insights from quantitative ultra‐performance liquid chromatography–mass spectrometry analysis. Biomedical Chromatography 2018; 32(10) doi: 10.1002/bmc.4320
|
| 40 |
Monika Berbecka, Alicja Forma, Jacek Baj, Marzena Furtak-Niczyporuk, Ryszard Maciejewski, Robert Sitarz. A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy. Journal of Clinical Medicine 2021; 10(19) doi: 10.3390/jcm10194443
|
| 41 |
Mihin Targu, Bishal Pun, Mamta Arora, Santa Ram Joshi, Suman Kumaria. Evaluation of bioactive compounds, antioxidant and antimicrobial properties of Bulbophyllum griffithii (Lindl.) Rchb.f., an unexplored rare orchid of therapeutic importance. South African Journal of Botany 2024; 174 doi: 10.1016/j.sajb.2024.08.049
|
| 42 |
Velko Minchev, Hristo Tsankov, Bozil Robev, Martin Takov, Stefan Federchev, Kalina Kamenova, Lozan Todorov, Liliya Atanasova, Nadya Hristova-Avakumova, Rumen Nikolov, Pavlina Gateva, Vanyo Mitev. Gastrointestinal Cancers with Consideration of DPD and UGT1A1 Plasma Levels: Chemotherapy-Related Toxicity. Life 2025; 15(7) doi: 10.3390/life15071071
|
| 43 |
Zongqiang Wang, Amanda Kasper, Mai Takahashi, Adrian Morales Amador, Abir Bhattacharjee, Jingbo Kan, Yozen Hernandez, Melinda Ternei, Sean F. Brady. Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn‐BNP)‐Coupled Metagenomics. Angewandte Chemie 2024; 136(17) doi: 10.1002/ange.202317187
|
| 44 |
Reetu Mukherji, John Marshall, Andreas Seeber. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers 2020; 12(8) doi: 10.3390/cancers12082001
|
| 45 |
Jasmine Chaudhary, Akash Jain, Garima Malik. Polymer-Drug Conjugates. 2023; doi: 10.1016/B978-0-323-91663-9.00001-1
|
| 46 |
Huafeng Jiang, Senjun Zhou, Gang Li. Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1189799
|
| 47 |
Claire Andre, Lydie Lethier, Yves Claude Guillaume. Long term and simulated in-use stabilities of irinotecan chemotherapy polyolefin infusion bags in dose banding conditions. Journal of Oncology Pharmacy Practice 2026; 32(7) doi: 10.1177/10781552251338763
|
| 48 |
Sergio C. Chai, William C. Wright, Taosheng Chen. Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer. Medicinal Research Reviews 2020; 40(3) doi: 10.1002/med.21648
|
| 49 |
Yong-Hee Cho, Eun Ji Ro, Jeong-Su Yoon, Tomohiro Mizutani, Dong-Woo Kang, Jong-Chan Park, Tae Il Kim, Hans Clevers, Kang-Yell Choi. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-19173-2
|
| 50 |
"Cholinergic side Effect-Free anticancer drugs: paving the way for safer and more effective cancer treatment". Journal of Biomolecular Structure and Dynamics 2024; 42(23) doi: 10.1080/07391102.2023.2274968
|
| 51 |
Isabella Lo, Sanika Vaidya, Ashley Mo, Alyssa Yee-Xin Chia, Katelyn Li, Jessica Parvin, Sripathy Sadagopan, Zane D’souza, Olivia Kwok, Jenny Zhang, Isa Baratoff, Shreya Somani, Lekhya Menta, Yining Xie, Thomas Sanchez, Terry Wang, Rebecca Chen, Akira Yamamoto, Joseph Pazzi, Edward Njoo. Blue Fluorescent Siloxytecans Exhibit Potent Anticancer Activity and Enable Direct Real-Time Quantification of Intracellular Uptake. ACS Bio & Med Chem Au 2026; 6(1) doi: 10.1021/acsbiomedchemau.5c00155
|
| 52 |
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Abdulqahar Azizkhan Mohammed, Mohammed Fatih Rasul, Ali M. Hussein, Solat Eslami, Mark C. Glassy, Mohammad Taheri. Advanced strategies of targeting circular RNAs as therapeutic approaches in colorectal cancer drug resistance. Pathology - Research and Practice 2024; 260 doi: 10.1016/j.prp.2024.155402
|
| 53 |
Maria M. Lukina, Marina A. Sirotkina, Anna G. Orlova, Varvara V. Dudenkova, Anastasia D. Komarova, Anton A. Plekhanov, Ludmila B. Snopova, Elena V. Zagaynova, Dmitri B. Papkovsky, Vladislav I. Shcheslavskiy, Marina V. Shirmanova. Effects of Irinotecan on Tumor Vasculature and Oxygenation: An in vivo Study on Colorectal Cancer Model. IEEE Journal of Selected Topics in Quantum Electronics 2021; 27(4) doi: 10.1109/JSTQE.2020.3047518
|
| 54 |
Armel J. Seukep, Victor Kuete. African plant-based products as a source of potent drugs to overcome cancers and their chemoresistance Part 1. Cancer chemoresistance, screening methods, and the updated cut-off points for the classification of natural cytotoxic products. Advances in Botanical Research 2024; 111 doi: 10.1016/bs.abr.2023.12.001
|
| 55 |
Rick-Léonid Ngoua Meye Misso, Fleury Augustin Nsole Biteghe, Cédric Sima Obiang, Joseph-Privat Ondo, Nan Gao, Miguel Cervantes-Cervantes, Guillaume Vignaux, Aurelia Vergeade, Jean Engohang-Ndong, Hugue Ella Mendene, Barthelemy Mabika, Félix Ovono Abessolo, Louis-Clement Obame Engonga, Jean De La Croix Ndong. Effect of aqueous extracts of Ficus vogeliana Miq and Tieghemella africana Pierre in 7,12-Dimethylbenz(a)anthracene -induced skin cancer in rats. Journal of Ethnopharmacology 2020; 263 doi: 10.1016/j.jep.2020.113244
|
| 56 |
Ruipu Sun, Ying Ying, Zhimin Tang, Ting Liu, Fuli Shi, Huixia Li, Taichen Guo, Shibo Huang, Ren Lai. The Emerging Role of the SLCO1B3 Protein in Cancer Resistance. Protein & Peptide Letters 2019; 27(1) doi: 10.2174/0929866526666190926154248
|
| 57 |
Tahia K. Mohamed, Rasha Z. Batran, Samia A. Elseginy, Mamdouh M. Ali, Abeer E. Mahmoud. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Bioorganic Chemistry 2019; 85 doi: 10.1016/j.bioorg.2018.12.040
|
| 58 |
Jing-Fang Zhang, Wan-Chao Zhong, Yan-Cheng Li, Yun-Qing Song, Gui-Yang Xia, Gui-Hua Tian, Guang-Bo Ge, Sheng Lin. Bioactivity-Guided Discovery of Human Carboxylesterase Inhibitors from the Roots of Paeonia lactiflora. Journal of Natural Products 2020; 83(10) doi: 10.1021/acs.jnatprod.0c00464
|
| 59 |
Chahat suri, Babita Pande, Lakkakula Suhani Sahithi, Shashikant Swarnkar, Tuneer Khelkar, Henu Kumar Verma. Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance. Cancer Drug Resistance 2025; doi: 10.20517/cdr.2024.164
|
| 60 |
Xian Zhao, Ruijie Xu, Yuanyuan Zhai, Yi Wang, Yuxin Zhang, Yuan Tian, Fengguo Xu, Pei Zhang. Liposomal Vardenafil and Linagliptin Combined with Irinotecan for Synergistic Colorectal Cancer Therapy. Pharmaceutical Research 2025; 42(6) doi: 10.1007/s11095-025-03876-6
|
| 61 |
Katy Vaillancourt, Amel Ben Lagha, Daniel Grenier. A green tea extract and epigallocatechin-3-gallate attenuate the deleterious effects of irinotecan in an oral epithelial cell model. Archives of Oral Biology 2021; 126 doi: 10.1016/j.archoralbio.2021.105135
|
| 62 |
Jia‐Nan Li, Yun‐Feng Cao, Rong‐Rong He, Guang‐Bo Ge, Bin Guo, Jing‐Jing Wu. Evidence for Shikonin acting as an active inhibitor of human carboxylesterases 2: Implications for herb–drug combination. Phytotherapy Research 2018; 32(7) doi: 10.1002/ptr.6062
|
| 63 |
Anne Kauffels, Marie Kitzmüller, Andrea Gruber, Hannah Nowack, Hanibal Bohnenberger, Melanie Spitzner, Anja Kuthning, Thilo Sprenger, Martin Czejka, Michael Ghadimi, Jens Sperling. Hepatic arterial infusion of irinotecan and EmboCept® S results in high tumor concentration of SN-38 in a rat model of colorectal liver metastases. Clinical & Experimental Metastasis 2019; 36(1) doi: 10.1007/s10585-019-09954-5
|
| 64 |
María de los Angeles Vázquez-Prieto, Adriana Sumoza-Toledo. The role of magnesium in colorectal cancer: mini-review. Oncologie 2026; doi: 10.1515/oncologie-2026-0058
|
| 65 |
Darren C. Phillips, Fritz G. Buchanan, Dong Cheng, Larry R. Solomon, Yu Xiao, John Xue, Stephen K. Tahir, Morey L. Smith, Haichao Zhang, Deborah Widomski, Vivek C. Abraham, Nan Xu, Zhihong Liu, Li Zhou, Enrico DiGiammarino, Xin Lu, Nandini Rudra-Ganguly, Bruce Trela, Susan E. Morgan-Lappe. Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors. Cancer Research 2021; 81(12) doi: 10.1158/0008-5472.CAN-20-2178
|
| 66 |
Jonathan P. Evans, Boleslaw K. Winiarski, Paul A. Sutton, Robert P. Jones, Lorenzo Ressel, Carrie A. Duckworth, D. Mark Pritchard, Zhi-Xiu Lin, Vicky L. Fretwell, Elizabeth M. Tweedle, Eithne Costello, Christopher E. Goldring, Ian M. Copple, B. Kevin Park, Daniel H. Palmer, Neil R. Kitteringham. The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer. Oncotarget 2018; 9(43) doi: 10.18632/oncotarget.25497
|
| 67 |
Thaise Boeing, Marcelo Biondaro Gois, Priscila de Souza, Lincon Bordignon Somensi, Débora de Mello Gonçales Sant´Ana, Luisa Mota da Silva. Irinotecan-induced intestinal mucositis in mice: a histopathological study. Cancer Chemotherapy and Pharmacology 2021; 87(3) doi: 10.1007/s00280-020-04186-x
|
| 68 |
Takeshi Kinoshita, Hajime Higuchi, Ayano- Kabashima-, Gen Sakai, Yasuo Hamamoto, Hiromasa Takaishi, Takanori Kanai. Analysis of Sensitivity and Cell Death Pathways Mediated by Anti-cancer Drugs Using Three-dimensional Culture System. International Journal of Cancer Research 2017; 14(1) doi: 10.3923/ijcr.2018.1.12
|
| 69 |
Mateusz Kciuk, Beata Marciniak, Renata Kontek. Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview. International Journal of Molecular Sciences 2020; 21(14) doi: 10.3390/ijms21144919
|
| 70 |
Carolina De la Guardia, David Stephens, Hang Dang, Mario Quijada, Oleg Larionov, Ricardo Lleonart. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. Molecules 2018; 23(3) doi: 10.3390/molecules23030672
|
| 71 |
Deysi Viviana Tenazoa Wong, Renata Brito Falcão Holanda, Aurilene Gomes Cajado, Alessandro Maia Bandeira, Jorge Fernando Bessa Pereira, Joice Oliveira Amorim, Clarice Sampaio Torres, Luana Maria Moura Ferreira, Marina Helena Silva Lopes, Roberta Taiane Germano Oliveira, Anamaria Falcão Pereira, Rosane Oliveira Sant'Ana, Larissa Mont'alverne Arruda, Howard Lopes Ribeiro‐Júnior, Ronald Feitosa Pinheiro, Paulo Roberto Carvalho Almeida, Robson Francisco Carvalho, Fábio Figueiredo Chaves, Duílio Reis Rocha‐Filho, Fernando Queiroz Cunha, Roberto César Pereira Lima‐Júnior. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea. British Journal of Pharmacology 2021; 178(20) doi: 10.1111/bph.15609
|
| 72 |
Satoru Sasagawa, Jun Kumai, Toru Wakamatsu, Yoshihiro Yui. Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer Innovation 2024; 3(2) doi: 10.1002/cai2.113
|
| 73 |
Sushobhan Chowdhury, Manisha Parlewar, Dheeraj Kashyap, Prerna Mahajan, Ranbeer Malhotra, Utkarsh Chauhan, Abhinav Parindiyal. Development of machine learning models for the precise identification of potential molecules active against pancreatic Cancer. Results in Chemistry 2026; 27 doi: 10.1016/j.rechem.2026.103425
|
| 74 |
Yan-Chi Li, Yu-Meng Xiong, Ze-Ping Long, Yi-Ping Huang, Yu-Bin Shu, Ke He, Hong-Yan Sun, Zhi Shi. ML210 Antagonizes ABCB1- Not ABCG2-Mediated Multidrug Resistance in Colorectal Cancer. Biomedicines 2025; 13(5) doi: 10.3390/biomedicines13051245
|
| 75 |
Gang Tang, Linyu Zhang. Update on Strategies of Probiotics for the Prevention and Treatment of Colorectal Cancer. Nutrition and Cancer 2022; 74(1) doi: 10.1080/01635581.2020.1865420
|
| 76 |
Yixuan Wang, Yujie Qin, Qian Kang, Huinan Wang, Shihong Zhou, Yifan Wu, Yongqi Liu, Yun Su, Yaqiong Guo, Minghui Xiu, Jianzheng He. Therapeutic potential of Astragalus membranaceus—Pueraria lobata decoction for the treatment of chemotherapy bowel injury. The FASEB Journal 2024; 38(19) doi: 10.1096/fj.202401677R
|
| 77 |
Justin C. Merritt, Stephen D. Richbart, Emily G. Moles, Ashley J. Cox, Kathleen C. Brown, Sarah L. Miles, Paul T. Finch, Joshua C. Hess, Maria T. Tirona, Monica A. Valentovic, Piyali Dasgupta. . 2021; doi: 10.2139/ssrn.3975294
|
| 78 |
Ranmali Ranasinghe, Michael Mathai, Anthony Zulli. A synopsis of modern - day colorectal cancer: Where we stand. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(2) doi: 10.1016/j.bbcan.2022.188699
|
| 79 |
Ayako Tsuboya, Ken-ichi Fujita, Yutaro Kubota, Hiroo Ishida, Iori Taki-Takemoto, Daisuke Kamei, Shinichi Iwai, Yasutsuna Sasaki. Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer. International Journal of Clinical Oncology 2019; 24(2) doi: 10.1007/s10147-018-1347-7
|
| 80 |
Sejal Chauhan, Raghu Solanki, Ashok Kumar Jangid, Poonam Jain, Pranjali Pranjali, Sunita Patel, Anupam Guleria, Deep Pooja, Hitesh Kulhari. Manganese nanocarrier for matrix metalloproteinase 9 responsive delivery of irinotecan for colon cancer treatment. Journal of Industrial and Engineering Chemistry 2023; 128 doi: 10.1016/j.jiec.2023.07.057
|
| 81 |
Susan J. Zunino, David H. Storms. Resveratrol-3-O-glucuronide and resveratrol-4′-O-glucuronide reduce DNA strand breakage but not apoptosis in Jurkat T cells treated with camptothecin. Oncology Letters 2017; 14(2) doi: 10.3892/ol.2017.6392
|
| 82 |
Chen Zhang, Catherine Hemmert, Heinz Gornitzka, Olivier Cuvillier, Ming Zhang, Raymond Wai‐Yin Sun. Cationic and Neutral N‐Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI‐60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation. ChemMedChem 2018; 13(12) doi: 10.1002/cmdc.201800181
|
| 83 |
Abdel B. Halim. Biomarkers, Diagnostics and Precision Medicine in the Drug Industry. 2019; doi: 10.1016/B978-0-12-816121-0.00003-9
|
| 84 |
Hailemeleak Regassa, Anuradha Sourirajan, Vikas Kumar, Sadanand Pandey, Deepak Kumar, Kamal Dev. A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers. Cancers 2022; 14(16) doi: 10.3390/cancers14163898
|
| 85 |
Gustavo Henrique Rodrigues da Silva, Ludmilla David de Moura, Fabíola Vieira de Carvalho, Gabriela Geronimo, Talita Cesarim Mendonça, Fernando Freitas de Lima, Eneida de Paula. Antineoplastics Encapsulated in Nanostructured Lipid Carriers. Molecules 2021; 26(22) doi: 10.3390/molecules26226929
|
| 86 |
Karien Sauruk da Silva, Bruna Carla da Silveira, Laryssa Regis Bueno, Liziane Cristine Malaquias da Silva, Lauany da Silva Fonseca, Elizabeth Soares Fernandes, Daniele Maria-Ferreira. Beneficial Effects of Polysaccharides on the Epithelial Barrier Function in Intestinal Mucositis. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.714846
|
| 87 |
Nada Oršolić, Maja Jazvinšćak Jembrek. Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy. Nutrients 2024; 16(21) doi: 10.3390/nu16213741
|
| 88 |
Lin Xiao, Weidong Dou, Yajie Wang, Huan Deng, Hao Xu, YiSheng Pan. Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice. Biochemical Pharmacology 2023; 216 doi: 10.1016/j.bcp.2023.115752
|
| 89 |
Lucia Scarabel, Marica Garziera, Sara Fortuna, Fioretta Asaro, Giuseppe Toffoli, Silvano Geremia. Soluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategy. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65424-z
|
| 90 |
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski, Zbigniew Kmieć. Therapeutic strategies against cancer stem cells in human colorectal cancer (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7261
|
| 91 |
Tianwei Xu, Mengwei Wang, Lihua Jiang, Li Ma, Li Wan, Qinnan Chen, Chenchen Wei, Zhaoxia Wang. CircRNAs in anticancer drug resistance: recent advances and future potential. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01240-3
|
| 92 |
Yan Wang, Yongxuan Zhang, Shiqi Yue, Menglu Liu, Kexin Li, Jinhan Wu, Junlong Wang, Minghui Xiu, Jianzheng He. Angelica sinensis polysaccharide ameliorates chemotherapy-induced intestinal mucositis by regulating gut microbiota-mediated innate immunity and short-chain fatty acid production in Drosophila and mice. International Journal of Biological Macromolecules 2026; 382 doi: 10.1016/j.ijbiomac.2026.154376
|
| 93 |
Anuradha Mehra, Amit Mittal, Rekha Sangwan. Innovative Nitrogen-Based Heterocycles: Pioneering Advances in Anticancer Therapeutics. Current Chemical Biology 2025; 19(2) doi: 10.2174/0122127968335169250107180240
|
| 94 |
Ana Lucić Vrdoljak, Nino Fuchs, Anja Mikolić, Suzana Žunec, Irena Brčić Karačonji, Andreja Jurič, Ljerka Prester, Vedran Micek, Marijana Neuberg, Samir Čanović, Gordan Mršić, Nevenka Kopjar. Irinotecan and Δ9-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers. Molecules 2018; 23(6) doi: 10.3390/molecules23061332
|
| 95 |
Morgan Brisset, Patrick Mehlen, Olivier Meurette, Frédéric Hollande. Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1231416
|
| 96 |
Myriam Mérarchi, Gautam Sethi, Lu Fan, Srishti Mishra, Frank Arfuso, Kwang Seok Ahn. Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models. Molecules 2018; 23(10) doi: 10.3390/molecules23102538
|
| 97 |
Zahra Nozhat, Shabnam Heydarzadeh, Mina Shahriari-Khalaji, Shibo Wang, M. Zubair Iqbal, Xiangdong Kong. Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery. Biomaterials Science 2023; 11(12) doi: 10.1039/D2BM01996E
|
| 98 |
Philip Emmerich, Linda Clipson, Dustin A. Deming. Resistance Mechanisms to Colorectal Cancer Therapeutics and the Clinical Implications. Current Colorectal Cancer Reports 2017; 13(4) doi: 10.1007/s11888-017-0374-5
|
| 99 |
Shimaa Kamal, Hamed Ahmed Derbala, Seham Soliman Alterary, Abir Ben Bacha, Mona Alonazi, Mohamed Kandeel El-Ashrey, Nahed Nasser Eid El-Sayed. Synthesis, Biological, and Molecular Docking Studies on 4,5,6,7-Tetrahydrobenzo[b]thiophene Derivatives and Their Nanoparticles Targeting Colorectal Cancer. ACS Omega 2021; 6(43) doi: 10.1021/acsomega.1c04063
|
| 100 |
Tugce Dilber, Gizem Damla Yalcin, Kubra Celikbas Yilmaz, Ahmet Acar. Phenotypic plasticity including drug efflux drives reversible irinotecan resistance in LIM1215 colorectal cancer cells. FEBS Letters 2026; 600(2) doi: 10.1002/1873-3468.70208
|
| 101 |
Shakilur Rahman, Amit Kumar Das. Integrated Multi-omics, Virtual Screening and Molecular Docking Analysis of Methicillin-Resistant Staphylococcus aureus USA300 for the Identification of Potential Therapeutic Targets: An In-Silico Approach. International Journal of Peptide Research and Therapeutics 2021; 27(4) doi: 10.1007/s10989-021-10287-9
|
| 102 |
Mohini Singh, Chitra Venugopal, Tomas Tokar, Nicole McFarlane, Minomi K. Subapanditha, Maleeha Qazi, David Bakhshinyan, Parvez Vora, Naresh K. Murty, Igor Jurisica, Sheila K. Singh. Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis. Cancer Research 2018; 78(17) doi: 10.1158/0008-5472.CAN-18-1022
|
| 103 |
Pieter H. du Preez, Kelly Breeds, N. Francois V. Burger, Hendrik W. Swiegers, J. Christoff Truter, Anna-Maria Botha. DNA Methylation and Demethylation Are Regulated by Functional DNA Methyltransferases and DnTET Enzymes in Diuraphis noxia. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00452
|
| 104 |
W. Placha, J. Zagajewski, P. Suder, M. Piwowar. A method of isolating and analysing drugs from cancer cells for preclinical research. Journal of Chromatography A 2022; 1682 doi: 10.1016/j.chroma.2022.463500
|
| 105 |
Yaqi Wang, Lifeng Yang, Jing Zhang, Menglong Zhou, Lijun Shen, Weijuan Deng, Liping Liang, Ran Hu, Wang Yang, Ye Yao, Hui Zhang, Zhen Zhang. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells . International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4514
|
| 106 |
Dia Advani, Sudhanshu Sharma, Smita Kumari, Rashmi K. Ambasta, Pravir Kumar. Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(3) doi: 10.2174/1871520621666210308101029
|
| 107 |
Andreja Jurič, Irena Brčić Karačonji, Uroš Gašić, Dušanka Milojković Opsenica, Saša Prđun, Dragan Bubalo, Dražen Lušić, Nada Vahčić, Nevenka Kopjar. Protective Effects of Arbutus unedo L. Honey in the Alleviation of Irinotecan-Induced Cytogenetic Damage in Human Lymphocytes—An In Vitro Study. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24031903
|
| 108 |
Caroline Molinaro, Alain Martoriati, Lydie Pelinski, Katia Cailliau. Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II. Cancers 2020; 12(10) doi: 10.3390/cancers12102863
|
| 109 |
. 2021; doi: 10.70675/75af9f5az2515z4a05z81f7z3294310d6a2d
|
| 110 |
Ah Reum Lim, Jwa Hoon Kim, Myung Han Hyun, Yeul Hong Kim, Soohyeon Lee. Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study. Supportive Care in Cancer 2022; 30(10) doi: 10.1007/s00520-022-07249-2
|
| 111 |
Shi-Jun Xi, Wen-Qi Cai, Qin-Qi Wang, Xiao-Chun Peng. Role of circular RNAs in gastrointestinal tumors and drug resistance. World Journal of Clinical Cases 2021; 9(34): 10400-10417 doi: 10.12998/wjcc.v9.i34.10400
|
| 112 |
Zheng Zhang, Meng Gu, Zhongze Gu, Yan-Ru Lou. Role of Long Non-Coding RNA Polymorphisms in Cancer Chemotherapeutic Response. Journal of Personalized Medicine 2021; 11(6) doi: 10.3390/jpm11060513
|
| 113 |
Liam Gillman, Djordji Suleski, Mark E. Graham, Samantha L. Ginn, Md. Musfizur Hassan. Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms. ACS Biomaterials Science & Engineering 2026; 12(8) doi: 10.1021/acsbiomaterials.6c00618
|
| 114 |
Ana Rita da Silva Ferreira, Anne-Grete Märtson, Alyse de Boer, Hannah R. Wardill, Jan-Willem Alffenaar, Hermie J. M. Harmsen, Wim J. E. Tissing. Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?. Biomedicines 2021; 9(10) doi: 10.3390/biomedicines9101389
|
| 115 |
Aleksandra Olszewska, Agata Borkowska, Monika Granica, Justyna Karolczak, Bartosz Zglinicki, Claudine Kieda, Halina Was. Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.738385
|
| 116 |
Discovery of natural inhibitors against gut bacterial β-glucuronidase from Arnebia euchroma for mitigating irinotecan-induced colitis. Phytomedicine 2026; 158 doi: 10.1016/j.phymed.2026.158383
|
| 117 |
Adrien Labriet, Elena De Mattia, Erika Cecchin, Éric Lévesque, Derek Jonker, Félix Couture, Angela Buonadonna, Mario D’Andrea, Lyne Villeneuve, Giuseppe Toffoli, Chantal Guillemette. Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00712
|
| 118 |
Yi-Shih Ma, Fu-Shin Chueh, Yi-Ping Huang, Shu-Fen Peng, Chao-Lin Kuo, Jaw-Chyun Chen, Fei-Ting Hsu, Kuang-Chi Lai, Yu-Jung Lin.
Triptolide enhances anti-cancer activities of irinotecan in human colon cancer HT-29 cells
in vitro
and HT-29 cell xenograft tumor model in nude mice
. Integrative Cancer Therapies 2026; 25 doi: 10.1177/15347354261448871
|
| 119 |
Jung Yoon Jang, Donghwan Kim, Nam Deuk Kim. Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors. International Journal of Molecular Sciences 2023; 24(9) doi: 10.3390/ijms24098457
|
| 120 |
Eknath D. Ahire, Sanjay J. Kshirsagar. Irinotecan's molecular mechanisms against cancer: a primary system biology and chemoinformatics approach for novel formulation development. Current Issues in Pharmacy and Medical Sciences 2025; 38(1) doi: 10.12923/cipms-2025-0005
|
| 121 |
Shawn J. Macha, Balakrishna Koneru, Trevor A. Burrow, Charles Zhu, Dzmitry Savitski, Rakhshanda L. Rahman, Catherine A. Ronaghan, Jonas Nance, Kristyn McCoy, Cody Eslinger, C. Patrick Reynolds. Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function. Cancer Research 2022; 82(18) doi: 10.1158/0008-5472.CAN-22-0125
|
| 122 |
Guiqin Ye, Mengting Xu, Yuhan Shu, Xin Sun, Yuanyuan Mai, Yupeng Hong, Jianbin Zhang, Jingkui Tian. A Quassinoid Diterpenoid Eurycomanone from Eurycoma longifolia Jack Exerts Anti-Cancer Effect through Autophagy Inhibition. Molecules 2022; 27(14) doi: 10.3390/molecules27144398
|
| 123 |
Danielle E. Large, Rudolf G. Abdelmessih, Elizabeth A. Fink, Debra T. Auguste. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Advanced Drug Delivery Reviews 2021; 176 doi: 10.1016/j.addr.2021.113851
|
| 124 |
Dylan T. Marsh, Scott D. Smid. The semi-synthetic flavonoid 2′,3′,4′-trihydroxyflavone (2-D08) inhibits both SN-38- and cytokine-evoked increases in epithelial barrier permeability in anin vitrointestinal mucositis model. Food & Function 2022; 13(21) doi: 10.1039/D2FO02458F
|
| 125 |
Gulay Dilek, Muhammed Tilahun Muhammed, Senem Akkoc. Synthesis, Antiproliferative Activity Evaluation, and Computational Insights of Benzo[d]imidazol‐2(3H)‐one Derivatives. ChemistrySelect 2025; 10(33) doi: 10.1002/slct.202503640
|
| 126 |
Sanjay Kumar, Yoshitaka Koseki, Keita Tanita, Aki Shibata, Asuka Mizutani, Hitoshi Kasai. SN-38-indoximod conjugate: carrier free nano-prodrug for cancer therapy. Therapeutic Delivery 2025; 16(3) doi: 10.1080/20415990.2025.2458449
|
| 127 |
Sabkat Mahmud, Alvira Ajadee, Arnob Sarker, Reaz Ahmmed, Tasfia Noor, Md. Al Amin Pappu, Md. Saiful Islam, Md. Nurul Haque Mollah, Suyan Tian. Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis. PLOS ONE 2025; 20(3) doi: 10.1371/journal.pone.0319028
|
| 128 |
Yanhao Jiang, Wenpan Li, Zhiren Wang, Jianqin Lu. Lipid-Based Nanotechnology: Liposome. Pharmaceutics 2023; 16(1) doi: 10.3390/pharmaceutics16010034
|
| 129 |
Ji-Eun Lee, Seung-Hwan Seo, Do-Won Ham, Eun-Hee Shin. Toxoplasma gondii GRA16 Suppresses Aerobic Glycolysis by Downregulating c-Myc and TERT Expressions in Colorectal Cancer Cells. Biomolecules & Therapeutics 2025; 33(4) doi: 10.4062/biomolther.2025.040
|
| 130 |
Elin Julianti, Ikram Ammar Abrian, Marlia Singgih Wibowo, Muhammad Azhari, Nadya Tsurayya, Fauzia Izzati, Ario Betha Juanssilfero, Asep Bayu, Siti Irma Rahmawati, Masteria Yunovilsa Putra. Secondary Metabolites from Marine-Derived Fungi and Actinobacteria as Potential Sources of Novel Colorectal Cancer Drugs. Marine Drugs 2022; 20(1) doi: 10.3390/md20010067
|
| 131 |
Hanna Peyerl, Gudrun Kreye, Martin Pecherstorfer, Josef Singer. Treatment of stage IV colorectal cancer: A retrospective cohort study assessing whether failure of first‑line treatment indicates failure of second‑line treatment. Molecular and Clinical Oncology 2024; 22(1) doi: 10.3892/mco.2024.2805
|
| 132 |
Shi-Yu Liu, Ren-Yu Qu, Rong-Rong Li, Yao-Chao Yan, Yao Sun, Wen-Chao Yang, Guang-Fu Yang. An Activity-Based Fluorogenic Probe Enables Cellular and in Vivo Profiling of Carboxylesterase Isozymes. Analytical Chemistry 2020; 92(13) doi: 10.1021/acs.analchem.0c01554
|
| 133 |
Advancement in therapeutic approach for treatment of metastatic colorectal cancer. Asia Pacific Journal of Molecular Biology and Biotechnology 2025; doi: 10.35118/apjmbb.2025.033.2.22
|
| 134 |
Shan Lu, Obinna N. Obianom, Yong Ai. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer. Bioorganic & Medicinal Chemistry Letters 2018; 28(17) doi: 10.1016/j.bmcl.2018.07.032
|
| 135 |
Yu Hou, Xiaoni Ai, Lin Zhao, Zhao Gao, Yujiang Wang, Yingyuang Lu, Pengfei Tu, Yong Jiang. An integrated biomimetic array chip for high-throughput co-culture of liver and tumor microtissues for advanced anticancer bioactivity screening. Lab on a Chip 2020; 20(14) doi: 10.1039/D0LC00288G
|
| 136 |
. 2024; doi: 10.70675/69ff325bz921az4e25zaceczf43a4ba7f5dd
|
| 137 |
Sara Gomes, Ana Catarina Rodrigues, Valerio Pazienza, Ana Preto. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy. International Journal of Molecular Sciences 2023; 24(6) doi: 10.3390/ijms24065069
|
| 138 |
Kuttiappan Anitha, Santenna Chenchula, Vijayaraj Surendran, Bhatt Shvetank, Parameswar Ravula, Rhythm Milan, Radhika Chikatipalli, Padmavathi R. RETRACTED: Advancing cancer theranostics through biomimetics: A comprehensive review. Heliyon 2024; 10(6) doi: 10.1016/j.heliyon.2024.e27692
|
| 139 |
Larissa Costa de Almeida, Anelize Bauermeister, Paula Rezende-Teixeira, Evelyne Alves dos Santos, Luiz Alberto Beraldo de Moraes, João Agostinho Machado-Neto, Leticia Veras Costa-Lotufo. Pradimicin-IRD exhibits antineoplastic effects by inducing DNA damage in colon cancer cells. Biochemical Pharmacology 2019; 168 doi: 10.1016/j.bcp.2019.06.016
|
| 140 |
Salique H. Shaham, Puneet Vij, Manish K. Tripathi. Advances in Targeted and Chemotherapeutic Strategies for Colorectal Cancer: Current Insights and Future Directions. Biomedicines 2025; 13(3) doi: 10.3390/biomedicines13030642
|
| 141 |
Santosh Kumar, Valid Gahramanov, Shivani Patel, Julia Yaglom, Lukasz Kaczmarczyk, Ivan A. Alexandrov, Gabi Gerlitz, Mali Salmon-Divon, Michael Y. Sherman. Evolution of Resistance to Irinotecan in Cancer Cells Involves Generation of Topoisomerase-Guided Mutations in Non-Coding Genome That Reduce the Chances of DNA Breaks. International Journal of Molecular Sciences 2023; 24(10) doi: 10.3390/ijms24108717
|
| 142 |
Faten Ahmad Alsulaimany, Haifa Almukadi, Nidal M. Omer Zabermawi, Thamer Abdulhamid Aljuhani, Omran M. Rashidi, Walaa F. Albaqami, Anwar A. Alghamdi, Aftab Ahmad, Noor Ahmad Shaik, Babajan Banaganapalli. Identification of novel mycobacterium tuberculosis leucyl-tRNA synthetase inhibitor using a knowledge-based computational screening approach. Journal of King Saud University - Science 2022; 34(4) doi: 10.1016/j.jksus.2022.102032
|
| 143 |
Chen Shaojun, Hua Li, Huang Haixin, Li Guisheng. Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer. Cancer Biology & Therapy 2018; 19(3) doi: 10.1080/15384047.2017.1414754
|
| 144 |
Sylvia Chen, Natalia Sutiman, Clara Zhenxian Zhang, Yingnan Yu, Shirley Lam, Chiea Chuen Khor, Balram Chowbay. Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review. Drug Metabolism Reviews 2016; 48(4) doi: 10.1080/03602532.2016.1226896
|
| 145 |
Ziqing Zeng, Yong Zheng, Xieqiao Yan, Jinping Tao, Liqiang Li, Jin Ding, Xi’nan Sheng, Hua Zhu, Zhi Yang. On the shoulder of ADC: The development of 124I-IMMU-132, an iodine-124-labelled Trop-2-targeting molecular probe for micro-PET imaging. Biomedicine & Pharmacotherapy 2024; 178 doi: 10.1016/j.biopha.2024.117151
|
| 146 |
. 2023; doi: 10.70675/98b43d98zd02bz42a9z89ebz27012480adda
|
| 147 |
Orkun Sarioglu, Ahmet Ergin Capar, Umit Belet. Colon Polyps and Colorectal Cancer. 2021; doi: 10.1007/978-3-030-57273-0_31
|
| 148 |
Suélen Karine Sartori, Marisa Alves Nogueira Diaz, Gaspar Diaz-Muñoz. Lactones: Classification, synthesis, biological activities, and industrial applications. Tetrahedron 2021; 84 doi: 10.1016/j.tet.2021.132001
|
| 149 |
Sustained release of epigallocatechin gallate from calcium carbonate nanoparticles: promising therapy for colorectal cancer. Applied Nanoscience 2025; 15(3) doi: 10.1007/s13204-025-03094-x
|
| 150 |
Ariana Pritha, Richard Anderson, David E Anderson, Theodore Nicolaides. A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma. Cureus 2022; doi: 10.7759/cureus.23447
|
| 151 |
. 2021; doi: 10.70675/68ea9779zddf2z4d17z9e21z2100d9fbb840
|
| 152 |
Kei Irie, Akira Okada, Yoshio Masuda, Keizo Fukushima, Nobuyuki Sugioka, Chiyuki Okuda, Akito Hata, Reiko Kaji, Yutaka Okada, Nobuyuki Katakami, Shoji Fukushima. Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy. Journal of Oncology Pharmacy Practice 2019; 25(4) doi: 10.1177/1078155218769136
|
| 153 |
Poonam Yadav, Priyanshu Sharma, Neha Chetlangia, Priyadharshini Mayalagu, Devarajan Karunagaran. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells. Chemico-Biological Interactions 2022; 368 doi: 10.1016/j.cbi.2022.110224
|
| 154 |
Teruki Nii, Shoichi Hijii, Ryosuke Kaneko, Kenta Tanito, Kota Yamanaka, Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama. In vitro evaluation of novel SN-38 prodrug activated by α-rhamnosidase of exogenous enzyme. Analytical Sciences 2024; 40(8) doi: 10.1007/s44211-024-00593-9
|
| 155 |
Rati Yadav, Rohit Bhawale, Vaibhavi Srivastava, Ekta Pardhi, Harshada Anil Bhalerao, Rajesh Sonti, Neelesh Kumar Mehra. Innovative Nanoparticulate Strategies in Colon Cancer Treatment: A Paradigm Shift. AAPS PharmSciTech 2024; 25(3) doi: 10.1208/s12249-024-02759-0
|
| 156 |
Divya Bharti Rai, Kanakaraju Medicherla, Deep Pooja, Hitesh Kulhari. Dendrimer-Mediated Delivery of Anticancer Drugs for Colon Cancer Treatment. Pharmaceutics 2023; 15(3) doi: 10.3390/pharmaceutics15030801
|
| 157 |
XuXin Sun, Maryam Sharifiaghdam, Nasim Sarrami, Ioana Popescu, Nicole Wretham, Nancy Dos Santos, Brent Sutherland, Ada W.Y. Leung, Tom Redelmeier, Mike Abram, Marcel Bally. A novel liposomal formulation of irinotecan comprising a combination of copper complexation and a transmembrane pH gradient to significantly improve irinotecan encapsulation and retention. International Journal of Pharmaceutics 2026; 700 doi: 10.1016/j.ijpharm.2026.127024
|
| 158 |
Da-Hyun Kim, Seul Lee, Hyeok Gu Kang, Hyun-Woo Park, Han-Woong Lee, Dongin Kim, Dong-Hoon Yoem, Jin-Hyung Ahn, Eunsin Ha, Weon-Kyoo You, Sang Hoon Lee, Seok-Jun Kim, Kyung-Hee Chun. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer. BMB Reports 2020; 53(10) doi: 10.5483/BMBRep.2020.53.10.103
|
| 159 |
Zhuo-Xun Wu, Yuqi Yang, Leli Zeng, Harsh Patel, Letao Bo, Lusheng Lin, Zhe-Sheng Chen. Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.624954
|
| 160 |
Semyon A. Sinyavskiy, Nelly S. Chmelyuk, Daria Yu. Travnikova, Vsevolod V. Belousov, Tatiana O. Abakumova. Combination Cancer Therapy and Reference Models for Assessing Drug Synergy in Glioblastoma. Current Oncology 2025; 33(1) doi: 10.3390/curroncol33010019
|
| 161 |
Andrea Idili, Netzahualcóyotl Arroyo-Currás, Kyle L. Ploense, Andrew T. Csordas, Masayasu Kuwahara, Tod E. Kippin, Kevin W. Plaxco. Seconds-resolved pharmacokinetic measurements of the chemotherapeutic irinotecan in situ in the living body. Chemical Science 2019; 10(35) doi: 10.1039/C9SC01495K
|
| 162 |
Nevenka Kopjar, Nino Fuchs, Irena Brčić Karačonji, Suzana Žunec, Anja Katić, Goran Kozina, Ana Lucić Vrdoljak. High Doses of Δ9-Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful Interactions. Clinical Drug Investigation 2020; 40(9) doi: 10.1007/s40261-020-00954-y
|
| 163 |
Yingqiang Cui, Yimeng Ou, Yongping Luo, Jiongbiao Yu, Yiguang Lin, Size Chen. Effective management of advanced colon cancer genotyping microsatellite stable/microsatellite instable-low with Kirsten rat sarcoma viral oncogene mutation using nivolumab plus ipilimumab combined with regorafenib and irinotecan: A case report. SAGE Open Medical Case Reports 2021; 9 doi: 10.1177/2050313X211027737
|
| 164 |
Xiang Li, Ting Liang, Si‐Si Chen, Meng Wang, Rui Wang, Kai Li, Ji‐Chang Wang, Chong‐Wen Xu, Ning Du, Sida Qin, Hong Ren. Matrine suppression of self‐renewal was dependent on regulation of LIN28A/Let‐7 pathway in breast cancer stem cells. Journal of Cellular Biochemistry 2020; 121(3) doi: 10.1002/jcb.29396
|
| 165 |
Sarah Allegra, Francesco Chiara, Giuliana Abbadessa, Asia Di Pietro, Maura Caudana, Silvia De Francia. Interactions between phytotherapeutics and chemotherapeutics: the current evidence. Expert Opinion on Drug Metabolism & Toxicology 2025; 21(7) doi: 10.1080/17425255.2025.2517733
|
| 166 |
Shubham Mehta, Iti Patel, Gautam Patel. Advances in pyrimidine-like heterocyclic scaffolds: Innovative synthetic method for malic enzyme inhibition in pancreatic ductal adenocarcinoma (PDAC) - A comprehensive review. European Journal of Medicinal Chemistry 2026; 307 doi: 10.1016/j.ejmech.2026.118657
|
| 167 |
Xiaoqin Yang, Heng Zhang, Chenglin He, Di Wang, Jingjing Li, Chaomei Fu, Yitao Wang, Yihan Wu, Jinming Zhang. Gegen Qinlian decoction remodels tumor immune microenvironment and inhibits aerobic glycolysis with the synergistic combination of CPT-11 chemotherapy in colorectal cancer therapy. Journal of Ethnopharmacology 2025; 344 doi: 10.1016/j.jep.2025.119538
|
| 168 |
Xando Díaz-Villamarín, María Teresa Nieto-Sánchez, María Martínez-Pérez, Paula Novo-González, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, José Cabeza-Barrera, Rocío Morón. Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review. Pharmaceutics 2025; 17(5) doi: 10.3390/pharmaceutics17050542
|
| 169 |
Seerwan Hamadameen Sulaiman, Hemn A. H. Barzani, Rebaz Anwar Omer, Zanco Hassan Jawhar, Ali Abdulhameed Mohammedsaeed. Comprehensive Overview of Therapeutic Strategies in Colon Cancer: Chemotherapy, Targeted Therapy, and Immunotherapy. Cell Biochemistry and Function 2026; 44(3) doi: 10.1002/cbf.70196
|
| 170 |
Nilanjan Sarkar, Sara Farheen, Mainak Chakraborty, Swarupananda Mukherjee, Pallab Kanti Haldar. Exploration of phytochemical and in-vitro antioxidant and antidiabetic properties of Aerva sanguinolenta (L.) Blume. Research Journal of Pharmacy and Technology 2022; doi: 10.52711/0974-360X.2022.00887
|
| 171 |
A. I. Fraguas-Sánchez, C. Martín-Sabroso, A. Fernández-Carballido, A. I. Torres-Suárez. Current status of nanomedicine in the chemotherapy of breast cancer. Cancer Chemotherapy and Pharmacology 2019; 84(4) doi: 10.1007/s00280-019-03910-6
|
| 172 |
Bin Yang, Xiangdong Ding, Jingkang Li, Jinyu Lai, Zhimin Zhang, Xiaohui Xu, Zhongling Liu, Zhiguang Song, Xinghua Wang, Bo Wang. Dihydroxanthene-derived fluorescent probe with near-infrared excitation and emission maxima for detecting human carboxylesterase-2 and bioimaging. Sensors and Actuators B: Chemical 2023; 395 doi: 10.1016/j.snb.2023.134503
|
| 173 |
Rohini Mahato, Dillip kumar Behera, Biswajit Patra, Shradhanjali Das, Kulwant Lakra, Surya Narayan Pradhan, Sk Jahir Abbas, Sk Imran Ali. Plant-based natural products in cancer therapeutics. Journal of Drug Targeting 2024; 32(4) doi: 10.1080/1061186X.2024.2315474
|
| 174 |
Danjun Wu, Lixi Zhu, Yi Li, Huiying Wang, Shumin Xu, Xueling Zhang, Rui Wu, Gensheng Yang. Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecan. International Journal of Pharmaceutics 2020; 584 doi: 10.1016/j.ijpharm.2020.119394
|
| 175 |
Yongqi Li, Dawei Zhao, Wenqiu Zhang, Miaomiao Yang, Zhihui Wu, Weiguo Shi, Shijie Lan, Zhen Guo, Hong Yu, Di Wu. A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04196-2
|
| 176 |
Balázs Pécsi, László Mangel. Real-Life Effectivity of Dose Intensity Reduction of First-Line mFOLFIRI-Based Treatment of Metastatic Colorectal Cancers: Sometimes Less Is More. Current Oncology 2023; 30(1) doi: 10.3390/curroncol30010069
|
| 177 |
Daniel R. Principe, Patrick W. Underwood, Murray Korc, Jose G. Trevino, Hidayatullah G. Munshi, Ajay Rana. The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.688377
|
| 178 |
Ruba Hamed, Sam Marks, Helen Mcelligott, Roshni Kalachand, Hawa Ibrahim, Said Atyani, Greg Korpanty, Nemer Osman. Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre). Molecular and Clinical Oncology 2021; 16(2) doi: 10.3892/mco.2021.2472
|
| 179 |
Adrien Labriet, Éric Lévesque, Erika Cecchin, Elena De Mattia, Lyne Villeneuve, Michèle Rouleau, Derek Jonker, Félix Couture, David Simonyan, Eric P. Allain, Angela Buonadonna, Mario D’Andrea, Giuseppe Toffoli, Chantal Guillemette. Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49477-3
|
| 180 |
Concetta Panebianco, Davide Ciardiello, Annacandida Villani, Brigida Anna Maiorano, Tiziana Pia Latiano, Evaristo Maiello, Francesco Perri, Valerio Pazienza. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective. Seminars in Cancer Biology 2022; 86 doi: 10.1016/j.semcancer.2021.11.007
|
| 181 |
Marina Gergues, Vibha Harindra Savanur, David Prado, Adam Eljarrah, James K. Liu, Mohammed Jaloudi, Pranela Rameshwar. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. 2021; doi: 10.1016/B978-0-12-821567-8.00012-9
|
| 182 |
Yaqiao Li, Carlota Pereda Serras, Jessica Blumenfeld, Min Xie, Yanxia Hao, Elise Deng, You Young Chun, Julia Holtzman, Alice An, Seo Yeon Yoon, Xinyu Tang, Antara Rao, Sarah Woldemariam, Alice Tang, Alex Zhang, Jeffrey Simms, Iris Lo, Tomiko Oskotsky, Michael J. Keiser, Yadong Huang, Marina Sirota. Cell-type-directed network-correcting combination therapy for Alzheimer’s disease. Cell 2025; 188(20) doi: 10.1016/j.cell.2025.06.035
|
| 183 |
Yu-Ting Shun, Hsien-Yung Lai, Yi-Ting Chuang, Hsuen-Fu Lin. Successful Treatment of Irinotecan-Induced Muscle Twitching: A Case Report. Clinical Medicine Insights: Case Reports 2023; 16 doi: 10.1177/11795476221150354
|
| 184 |
Francesco Carli, Pierluigi Di Chiaro, Mariangela Morelli, Chakit Arora, Luisa Bisceglia, Natalia De Oliveira Rosa, Alice Cortesi, Sara Franceschi, Francesca Lessi, Anna Luisa Di Stefano, Orazio Santo Santonocito, Francesco Pasqualetti, Paolo Aretini, Pasquale Miglionico, Giuseppe R. Diaferia, Fosca Giannotti, Pietro Liò, Miquel Duran-Frigola, Chiara Maria Mazzanti, Gioacchino Natoli, Francesco Raimondi. Learning and actioning general principles of cancer cell drug sensitivity. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-56827-5
|
| 185 |
J. Kashifa Fathima, V. Lavanya, Shazia Jamal, Neesar Ahmed. The Effectiveness of Various Chemotherapeutic Agents in Cancer Treatment. Current Pharmacology Reports 2022; 8(4) doi: 10.1007/s40495-022-00289-6
|
| 186 |
Fang-Ting Pai, Wen Jen Lin. Synergistic cytotoxicity of irinotecan combined with polysaccharide-based nanoparticles for colorectal carcinoma. Biomaterials Advances 2023; 153 doi: 10.1016/j.bioadv.2023.213577
|
| 187 |
Ayako Tsuboya, Yutaro Kubota, Hiroo Ishida, Ryotaro Ohkuma, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Takuya Tsunoda, Yasutsuna Sasaki, Natsumi Matsumoto, Yusuke Kondo, Yukana Tomoda, Hiroyuki Kusuhara, Ken-ichi Fujita. Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure. Cancer Chemotherapy and Pharmacology 2021; 88(3) doi: 10.1007/s00280-021-04314-1
|
| 188 |
Shan Lu, Obinna N. Obianom, Yong Ai. Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo. MedChemComm 2018; 9(10) doi: 10.1039/C8MD00284C
|
| 189 |
Laura Gavrilas, Oana Sava, Loredana Balacescu, Stefan Miron, Doina Miere, Ovidiu Balacescu, Daniel Cruceriu. Curcumin reverses irinotecan-acquired resistance in DLD1 colorectal cancer cells: Insights from whole transcriptomic data. Biochemical Pharmacology 2025; 242 doi: 10.1016/j.bcp.2025.117386
|
| 190 |
Hiroto Fujita, Yuka Kataoka, Masayasu Kuwahara. Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin Gels. Applied Sciences 2020; 10(23) doi: 10.3390/app10238755
|
| 191 |
Yeliz Benli, Helin Arıkan, Özge Akbulut-Çalışkan. HER2-targeted therapy in colorectal cancer: a comprehensive review. Clinical and Translational Oncology 2025; 27(9) doi: 10.1007/s12094-025-03887-0
|
| 192 |
Dimitra-Ioanna Lampropoulou, Gerasimos Aravantinos, Hector Katifelis, Foivos Lazaris, Konstantinos Laschos, Theodosios Theodosopoulos, Christos Papadimitriou, Maria Gazouli. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer. Cancer Biomarkers 2019; 25(2) doi: 10.3233/CBM-182383
|
| 193 |
Alice Meroni, Jan Grosser, Sumedha Agashe, Natasha Ramakrishnan, Jessica Jackson, Priyanka Verma, Laura Baranello, Alessandro Vindigni. NEDDylated Cullin 3 mediates the adaptive response to topoisomerase 1 inhibitors. Science Advances 2022; 8(49) doi: 10.1126/sciadv.abq0648
|
| 194 |
Elena De Mattia, Erika Cecchin, Rossana Roncato, Giuseppe Toffoli. Pregnane X Receptor, Constitutive Androstane Receptor and Hepatocyte Nuclear Factors as Emerging Players in Cancer Precision Medicine. Pharmacogenomics 2016; 17(14) doi: 10.2217/pgs-2016-0095
|
| 195 |
A.I. Fraguas-Sanchez, C. Martin-Sabroso, A. Fernandez-Carballido, A.I. Torres-Suarez. Targeted Nanomedicine for Breast Cancer Therapy. 2022; doi: 10.1016/B978-0-12-824476-0.00014-0
|
| 196 |
Mary O’Reilly, Anna Linehan, Aleksandar Krstic, Walter Kolch, Kieran Sheahan, Des C. Winter, Ray Mc Dermott. Oncotherapeutic Strategies in Early Onset Colorectal Cancer. Cancers 2023; 15(2) doi: 10.3390/cancers15020552
|
| 197 |
Prince Prajapati, Siddharth Thakkar, Hetal Thakkar. Irinotecan Hydrochloride Nanosuspension Loaded Beads for Colon Targeting: In-Vitro and In-Vivo Characterization. BioNanoScience 2026; 16(6) doi: 10.1007/s12668-026-02639-w
|
| 198 |
The Hong Phong Nguyen, V. Bharath Kumar, Vinoth Kumar Ponnusamy, Thi Thu Thao Mai, Phuong Tran Nhat, Kathirvel Brindhadevi, Arivalagan Pugazhendhi. Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy. Process Biochemistry 2021; 104 doi: 10.1016/j.procbio.2021.02.004
|
| 199 |
Zongqiang Wang, Amanda Kasper, Mai Takahashi, Adrian Morales Amador, Abir Bhattacharjee, Jingbo Kan, Yozen Hernandez, Melinda Ternei, Sean F. Brady. Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn‐BNP)‐Coupled Metagenomics. Angewandte Chemie International Edition 2024; 63(17) doi: 10.1002/anie.202317187
|
| 200 |
Sara Rahiminejad, Mano R. Maurya, Kavitha Mukund, Shankar Subramaniam. Modular and mechanistic changes across stages of colorectal cancer. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09479-3
|
| 201 |
MAHALEKSHMI V., BALAKRISHNAN N., AJAY KUMAR T. V., PARTHASARATHY V.. IN SILICO MOLECULAR SCREENING AND DOCKING APPROACHES ON ANTINEOPLASTIC AGENT-IRINOTECAN TOWARDS THE MARKER PROTEINS OF COLON CANCER. International Journal of Applied Pharmaceutics 2023; doi: 10.22159/ijap.2023v15i5.48523
|
| 202 |
Fabio Gosetti, Masho Hilawie Belay, Emilio Marengo, Elisa Robotti. Development and validation of a UHPLC-MS/MS method for the identification of irinotecan photodegradation products in water samples. Environmental Pollution 2020; 256 doi: 10.1016/j.envpol.2019.113370
|
| 203 |
Aneela Gulnaz, Kyeong-Ryoon Lee, Min-Ji Kang, Ji-Eun Chang, Yoon-Jee Chae. Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions. Toxicology Letters 2024; 394 doi: 10.1016/j.toxlet.2024.02.011
|
| 204 |
Yuan Zhang, Cheng Zhao, Yongwei Zhao, Senzhen Wang, Zhengwei Guo, Wei Guo, Pushuai Wen, Yujun Hao, Wei Li, Yanming Wang, Yamu Li. SERPINA3 mediates liver cancer cells escape from chemotherapy-induced neutrophil extracellular trap killing. Cell Reports 2026; 45(2) doi: 10.1016/j.celrep.2026.116956
|
| 205 |
Nibas Kumar Pal, Md. Kaderi Kibria, Tasfia Noor, Md. Feroj Ahmed, Md. Shariful Islam, Md. Foysal Ahmed, Md. Abdul Latif, Mohammad Ali, Md. Al Noman, Dipto Kundu, Ovi Sharma, Md. Nurul Haque Mollah, Filomena de Nigris. In-silico identification of bacterial key-genes directly or indirectly associated with the development and progression of colorectal cancer for exploring anti-bacterial agents. PLOS One 2026; 21(6) doi: 10.1371/journal.pone.0343565
|
| 206 |
Yan-Yan Zhu, Qiong Jin, Shan-Shan Chen, Dan-Ni Jin, Zhao-Jie Wang, Ying-Jie He, Hui-Cheng Chen, Yun-Li Zhao, Li-Xing Zhao, Zhi Dai, Xiao-Dong Luo. Neothalfine, a potent natural anti-tumor agent against metastatic colorectal cancer and its primary mechanism. Bioorganic & Medicinal Chemistry 2021; 29 doi: 10.1016/j.bmc.2020.115849
|
| 207 |
Minyue Jia, Liya Lin, Hanxiao Yu, Zhichao Dong, Xin Pan, Xiaoxiao Song. Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-85900-8
|
| 208 |
Heber Uriel Pérez-Ortega, Rubén Ricardo Córdova-Espíritu, Sebastian Cano-Serrano, Eduardo García-González, Micael Gerardo Bravo-Sánchez, Ma. del Carmen Orozco-Mosqueda, Hugo Jiménez-Islas, Gabriel Luna-Bárcenas, Francisco Villaseñor-Ortega. Camptothecin in Cancer Therapy: Current Challenges and Emerging Strategies with Nanoemulsions. Pharmaceutics 2025; 17(11) doi: 10.3390/pharmaceutics17111414
|
| 209 |
Xing He, Huanrong Lan, Ketao Jin, Fanlong Liu. Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1237764
|
| 210 |
Boah Lee, Jeong A. Min, Abdullateef Nashed, Sang-Ok Lee, Jae Cheal Yoo, Seung-Wook Chi, Gwan-Su Yi. A novel mechanism of irinotecan targeting MDM2 and Bcl-xL. Biochemical and Biophysical Research Communications 2019; 514(2) doi: 10.1016/j.bbrc.2019.04.009
|
| 211 |
Riccardo Rampado, Sara Crotti, Paolo Caliceti, Salvatore Pucciarelli, Marco Agostini. Nanovectors Design for Theranostic Applications in Colorectal Cancer. Journal of Oncology 2019; 2019 doi: 10.1155/2019/2740923
|
| 212 |
Sára Lenárt, Peter Lenárt, Jan Šmarda, Ján Remšík, Karel Souček, Petr Beneš. Trop2: Jack of All Trades, Master of None. Cancers 2020; 12(11) doi: 10.3390/cancers12113328
|
| 213 |
Ilya Turchin, Shazia Bano, Mikhail Kirillin, Anna Orlova, Valeriya Perekatova, Vladimir Plekhanov, Ekaterina Sergeeva, Daria Kurakina, Aleksandr Khilov, Alexey Kurnikov, Pavel Subochev, Marina Shirmanova, Anastasiya Komarova, Diana Yuzhakova, Alena Gavrina, Srivalleesha Mallidi, Tayyaba Hasan. Combined Fluorescence and Optoacoustic Imaging for Monitoring Treatments against CT26 Tumors with Photoactivatable Liposomes. Cancers 2021; 14(1) doi: 10.3390/cancers14010197
|
| 214 |
Dmitry O. Tsypyshev, Artem M. Klabukov, Daria N. Razgulaeva, Anastasia V. Galochkina, Anna A. Shtro, Sophia S. Borisevich, Tatyana M. Khomenko, Konstantin P. Volcho, Nina I. Komarova, Nariman F. Salakhutdinov. Design, synthesis and antiviral evaluation of triazole-linked 7-hydroxycoumarin–monoterpene conjugates as inhibitors of RSV replication. RSC Medicinal Chemistry 2025; 16(3) doi: 10.1039/D4MD00728J
|
| 215 |
Ghazala Muteeb, Rawan S. Elsharkawy, Ayda H. El‐Gouhari, Ghannimah Yousef Alghuwainem, Mohammad Aatif, Doaa S. R. Khafaga. Delivery System and Nanozyme: Nanotechnology‐Based Natural Sources Promise New Approaches in Colorectal Cancer Management. Micro & Nano Letters 2026; 21(1) doi: 10.1049/mna2.70020
|
| 216 |
Su Min Cho, Abdullah Esmail, Maen Abdelrahim. Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.795381
|
| 217 |
Mei-Qi Xu, Ting Zhong, Xin Yao, Zhuo-Yue Li, Hui Li, Jing-Ru Wang, Zhen-Han Feng, Xuan Zhang. Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles. Drug Delivery 2021; 28(1) doi: 10.1080/10717544.2021.1958107
|
| 218 |
Ana Baião, Flávia Castro, Juliana Viegas, Andreia S. Barros, Sofia Dias, Carla Oliveira, Bruno Sarmento. Targeted nanoparticle delivery of irinotecan enhances tumor response to PD-L1 blockade in colorectal cancer. Journal of Controlled Release 2026; 391 doi: 10.1016/j.jconrel.2026.114609
|
| 219 |
Jinhan Wu, Minghui Xiu, Xiaoqian Wang, Peihao Zhang, Yujie Qin, Jiangnan Li, Xiaolin Jiang, Yaoxing Duan, Yongqi Liu, Jianzheng He. Dunhuang Gancao Fuling Xingren decoction and its components alleviate CPT-11 induced intestinal mucositis by regulating gut microbiota related innate immunity and inflammatory response in Drosophila and mice. Chinese Medicine 2026; 21(1) doi: 10.1186/s13020-025-01279-8
|
| 220 |
Smitha S. Bhat, M. Thanmaya, Sushma Jahagirdar, C.R. Akshatha, Shashanka K. Prasad, R. Sindhu. Biochemical and Molecular Pharmacology in Drug Discovery. 2024; doi: 10.1016/B978-0-443-16013-4.00020-8
|
| 221 |
Côme Emmenecker, Jingqi Dai, Sandrine Lefranc, Ayoub Ouddah, Julie Guerin, Simine Pakzad, Philippe Andrey, Rajeev Kumar. A high-throughput differential chemical genetic screen uncovers genotype-specific compounds altering plant growth. iScience 2025; 28(5) doi: 10.1016/j.isci.2025.112375
|
| 222 |
Tatyana Khomenko, Alexandra Zakharenko, Tatyana Odarchenko, Homayon John Arabshahi, Victoriya Sannikova, Olga Zakharova, Dina Korchagina, Jóhannes Reynisson, Konstantin Volcho, Nariman Salakhutdinov, Olga Lavrik. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties. Bioorganic & Medicinal Chemistry 2016; 24(21) doi: 10.1016/j.bmc.2016.09.016
|
| 223 |
Filippos Panteleimon Chatzipieris, Kiriaki Mavromoustakou, John M. Matsoukas, Thomas Mavromoustakos. Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers. International Journal of Molecular Sciences 2025; 26(18) doi: 10.3390/ijms26188819
|
| 224 |
Wen Luo, Qingan Liu, Xinwen Chen, Haijun Liu, Bin Quan, Jinli Lu, Ke Zhang, Xiangling Wang, Junyan Liu. [Retracted] FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+‐ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/9986376
|
| 225 |
Mei Chen, Hongbing Liu, Mengqi Xiu, Muse Ji, Dongmei Shi, Jingxin Gou, Haibing He, Tian Yin, Xing Tang, Guoliang Chen, Yu Zhang. Irinotecan and dexamethasone prodrug co-loaded liposomes for the treatment of breast cancer. Journal of Controlled Release 2025; 385 doi: 10.1016/j.jconrel.2025.114017
|
| 226 |
Madhusmita Dhupal, Devasish Chowdhury. <p>Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use</p>. International Journal of Nanomedicine 2020; doi: 10.2147/IJN.S259628
|
| 227 |
Benny Mosoane, Georgios Lolas, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00014-7
|
| 228 |
Mark Kerstjens, Patricia Garrido Castro, Sandra S. Pinhanços, Pauline Schneider, Priscilla Wander, Rob Pieters, Ronald W. Stam. Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia. Biomedicines 2021; 9(7) doi: 10.3390/biomedicines9070711
|
| 229 |
Jinhee Kim, Hye-Youn Kim, Suntaek Hong, Sarah Shin, Young Ah Kim, No Soo Kim, Ok-Sun Bang. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model. Biomedicine & Pharmacotherapy 2019; 116 doi: 10.1016/j.biopha.2019.108987
|
| 230 |
Alexandra Zakharenko, Olga Luzina, Olga Koval, Dmitry Nilov, Irina Gushchina, Nadezhda Dyrkheeva, Vytas Švedas, Nariman Salakhutdinov, Olga Lavrik. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin. Journal of Natural Products 2016; 79(11) doi: 10.1021/acs.jnatprod.6b00979
|
| 231 |
Madhumita Roy, Amitava Datta. Cancer Genetics and Therapeutics. 2019; doi: 10.1007/978-981-13-9471-3_7
|
| 232 |
Christian Marx, Jürgen Sonnemann, Mandy Beyer, Oliver D. K. Maddocks, Sergio Lilla, Irene Hauzenberger, Andrea Piée‐Staffa, Kanstantsin Siniuk, Suneetha Nunna, Lisa Marx‐Blümel, Martin Westermann, Tobias Wagner, Felix B. Meyer, René Thierbach, Christina S. Mullins, Said Kdimati, Michael Linnebacher, Francesco Neri, Thorsten Heinzel, Zhao‐Qi Wang, Oliver H. Krämer. Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells. Molecular Oncology 2021; 15(12) doi: 10.1002/1878-0261.13060
|
| 233 |
Chiara Pierantoni, Lorenzo Cosentino, Luigi Ricciardiello. Molecular Pathways of Colorectal Cancer Development: Mechanisms of Action and Evolution of Main Systemic Therapy Compunds. Digestive Diseases 2024; 42(4) doi: 10.1159/000538511
|
| 234 |
Qiao Yijie, Wang Xuejun, Xin Yuanyao, Nian Yongqiong, Yang Jianxin, Duan Yabin, Li Xiangyang. Effect of X‐ray irradiation on pharmacokinetics of irinotecan hydrochloride and expression of CES1 and CYP3A1 in rats. Fundamental & Clinical Pharmacology 2019; 33(5) doi: 10.1111/fcp.12456
|
| 235 |
Moustafa M. Madkour, Wafaa S. Ramadan, Ekram Saleh, Raafat El-Awady. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2203946
|
| 236 |
Hiu Ting Chan, Yoon Ming Chin, Siew-Kee Low. The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics. Oncology and Therapy 2019; 7(1) doi: 10.1007/s40487-018-0090-6
|
| 237 |
Zenib Aljadi, Negar Abbasi Aval, Tharagan Kumar, Taoyu Qin, Harisha Ramachandraiah, Torbjörn Pettersson, Aman Russom. Layer‐by‐Layer Cellulose Nanofibrils: A New Coating Strategy for Development and Characterization of Tumor Spheroids as a Model for In Vitro Anticancer Drug Screening. Macromolecular Bioscience 2022; 22(10) doi: 10.1002/mabi.202200137
|
| 238 |
Mohsen Fatemi, Azadeh Meshkini, Maryam M. Matin. A dual catalytic functionalized hollow mesoporous silica-based nanocarrier coated with bacteria-derived exopolysaccharides for targeted delivery of irinotecan to colorectal cancer cells. International Journal of Biological Macromolecules 2024; 259 doi: 10.1016/j.ijbiomac.2023.129179
|
| 239 |
Christie Habchi, Adnan Badran, Mortada Srour, Anis Daou, Elias Baydoun, Kamar Hamade, Akram Hijazi. Determination of the Antioxidant and Antiproliferative Properties of Pomegranate Peel Extract Obtained by Ultrasound on HCT-116 Colorectal Cancer Cell Line. Processes 2023; 11(4) doi: 10.3390/pr11041111
|
| 240 |
Jin Wang, Li Shao, Chong-Zhi Wang, Hong-Hao Zhou, Chun-Su Yuan, Wei-Hua Huang. Synergetic Inhibition of Human Colorectal Cancer Cells by Combining Polyyne-Enriched Fraction from Oplopanax elatus and Irinotecan. Nutrition and Cancer 2019; 71(3) doi: 10.1080/01635581.2018.1516788
|
| 241 |
. 2024; doi: 10.70675/58dba8b7z92c0z469fz82cbze5a61f345993
|
| 242 |
Octav Ginghină, Ariana Hudiță, Cătălin Zaharia, Aristidis Tsatsakis, Yaroslav Mezhuev, Marieta Costache, Bianca Gălățeanu. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients. Materials 2021; 14(9) doi: 10.3390/ma14092440
|
| 243 |
J. Lapoirie, L. Tran, L. Piazza, C. Contin-Bordes, M. E. Truchetet, F. Bonnet. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-97538-3
|
| 244 |
Nicolaos Achilleos, Maddox Talbot Harrison, Evangelia Tsiani. Epigallocatechin-3-Gallate (EGCG) as a Multifaceted Natural Anticancer Agent in Colorectal Cancer: Preclinical Evidence and Future Directions. Cancers 2026; 18(15) doi: 10.3390/cancers18152391
|
| 245 |
Beata Naumczuk, Jerzy Sitkowski, Wojciech Bocian, Magdalena Stolarska, Elżbieta Bednarek, Lech Kozerski. A NMR study of binding the metabolite of SN38 derivatives to a model nicked DNA decamer mimicking target of Topo I inhibitors. Bioorganic Chemistry 2021; 107 doi: 10.1016/j.bioorg.2021.104631
|
| 246 |
Cuc Thi Thu Nguyen, Thi Minh Thuy Nguyen, Thanh Huong Phung.
Meta-analysis revisiting the influence of
UGT1A1*28
and
UGT1A1*6
on irinotecan safety in colorectal cancer patients
. Pharmacogenomics 2024; 25(10-11) doi: 10.1080/14622416.2024.2385289
|
| 247 |
Zhiyu Wang, Aimin Zang, Yaning Wei, Lin An, Dan Hong, Yan Shi, Jingnan Zhang, Shenyong Su, Guotao Fang. <p>Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer</p>. Drug Design, Development and Therapy 2020; doi: 10.2147/DDDT.S230306
|
| 248 |
Jennifer Chiou, Valeria Impedovo, Yen Bao Huynh, Ruggiero Gorgoglione, Luiz O. F. Penalva, Alessia Lodi, Andrew J. Brenner, Stefano Tiziani. Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with SN-38 and Rabusertib Combination Therapy. International Journal of Molecular Sciences 2025; 26(2) doi: 10.3390/ijms26020474
|
| 249 |
Alvira Ajadee, Sabkat Mahmud, Md. Bayazid Hossain, Reaz Ahmmed, Md. Ahad Ali, Md. Selim Reza, Saroje Kumar Sarker, Md. Nurul Haque Mollah, Yuki Arita. Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma. PLOS ONE 2024; 19(9) doi: 10.1371/journal.pone.0310843
|
| 250 |
Xue Zhang, Jia-Fu Yin, Jiao Zhang, Shu-Jia Kong, Hong-Yin Zhang, Xue-Mei Chen. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis. Cancer Chemotherapy and Pharmacology 2017; 80(1) doi: 10.1007/s00280-017-3344-3
|
| 251 |
Kseniya Kovaleva, Olga Yarovaya, Konstantin Ponomarev, Sergey Cheresiz, Amirhossein Azimirad, Irina Chernyshova, Alexandra Zakharenko, Vasily Konev, Tatiana Khlebnikova, Evgenii Mozhaytsev, Evgenii Suslov, Dmitry Nilov, Vytas Švedas, Andrey Pokrovsky, Olga Lavrik, Nariman Salakhutdinov. Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties. Pharmaceuticals 2021; 14(5) doi: 10.3390/ph14050422
|
| 252 |
Yabing Liang, Miao Wang, Xianjue Wang, Zhiqing Yang, Shucheng Wang, Fengyi Li, Liya Su, Ling Yang. Cellular senescence in colorectal cancer: its occurrence, effect and therapy. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1580951
|
| 253 |
Maria Virginia Giolito, Serguei Bodoirat, Theo La Rosa, Mathieu Reslinger, Gabriela D. A. Guardia, Jana Mourtada, Leo Claret, Alain Joung, Pedro A. F. Galante, Luiz O. F. Penalva, Michelina Plateroti. Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies. Cell Death & Disease 2024; 15(5) doi: 10.1038/s41419-024-06690-x
|
| 254 |
Silpa Narayanan, Nehaben A. Gujarati, Jing-Quan Wang, Zhuo-Xun Wu, Jagadish Koya, Qingbin Cui, Vijaya L. Korlipara, Charles R. Ashby, Jr. Chen. The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter. International Journal of Molecular Sciences 2021; 22(5) doi: 10.3390/ijms22052463
|
| 255 |
Luana David do Carmo, Gisele de Fátima Pinheiro Rangel, Liviane Maria Alves Rabelo, Tamiris de Fátima Goebel de Souza, Roberto César Pereira Lima Júnior, Deysi Viviana Tenazoa Wong, Renata Ferreira de Carvalho Leitão, Alfredo Augusto Vasconcelos da Silva, Pedro Jorge Caldas Magalhães, Andréa Santos Costa, Dyély de Carvalho Oliveira Campos, Nylane Maria Nunes de Alencar, Hermógenes David de Oliveira. Therapeutic effects of a lipid transfer protein isolated from Morinda citrifolia L. (noni) seeds on irinotecan-induced intestinal mucositis in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(9) doi: 10.1007/s00210-022-02267-7
|
| 256 |
Michèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, Antoine Adenis, Jean Luc Raoul, Thierry Lecomte, You Heng Lam, Roger Faroux, Claude Masliah, Anne Lise Poirier, Virginie Berger, Alain Morel, Erick Gamelin. A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification. Seminars in Oncology 2017; 44(1) doi: 10.1053/j.seminoncol.2017.02.007
|
| 257 |
Rachel A. Crane, Emery S. Grubb, Lori U. Coward, Greg S. Gorman.
In vitro metabolic biomodulation of irinotecan to increase potency and reduce dose-limiting toxicity by inhibition of SN-38 glucuronide formation. Drug Metabolism and Personalized Therapy 2022; 37(3) doi: 10.1515/dmpt-2021-0178
|
| 258 |
Stephane Ferretti, Jacques Hamon, Ruben de Kanter, Clemens Scheufler, Rita Andraos-Rey, Stephanie Barbe, Elisabeth Bechter, Jutta Blank, Vincent Bordas, Ernesta Dammassa, Andrea Decker, Noemi Di Nanni, Marion Dourdoigne, Elena Gavioli, Marc Hattenberger, Alisa Heuser, Christelle Hemmerlin, Jürgen Hinrichs, Grainne Kerr, Laurent Laborde, Isabel Jaco, Eloísa Jiménez Núñez, Hans-Joerg Martus, Cornelia Quadt, Markus Reschke, Vincent Romanet, Fanny Schaeffer, Joseph Schoepfer, Maxime Schrapp, Ross Strang, Hans Voshol, Markus Wartmann, Sarah Welly, Frédéric Zécri, Francesco Hofmann, Henrik Möbitz, Marta Cortés-Cros. Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers. Nature 2024; 629(8011) doi: 10.1038/s41586-024-07350-y
|
| 259 |
Elke Cario. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity. Current Opinion in Supportive & Palliative Care 2016; 10(2) doi: 10.1097/SPC.0000000000000202
|
| 260 |
Yihan Wu, Yanfen Cheng, Yuhan Yang, Di Wang, Xiaoqin Yang, Chaomei Fu, Jinming Zhang, Yichen Hu. Mechanisms of Gegen Qinlian Pill to ameliorate irinotecan-induced diarrhea investigated by the combination of serum pharmacochemistry and network pharmacology. Journal of Ethnopharmacology 2021; 276 doi: 10.1016/j.jep.2021.114200
|
| 261 |
Fatima Hameedat, Nuria A. Pizarroso, Natália Teixeira, Soraia Pinto, Bruno Sarmento. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment. European Journal of Pharmaceutical Sciences 2022; 176 doi: 10.1016/j.ejps.2022.106259
|
| 262 |
Álvaro Esteban Alfaro Alfaro, Brayan Murillo Castillo, Eugenia Cordero García, Javier Tascón, Ana I. Morales. Colon Cancer Pharmacogenetics: A Narrative Review. Pharmacy 2022; 10(4) doi: 10.3390/pharmacy10040095
|
| 263 |
Shreyasi Mukherjee, Anuja Kulkarni, Joseph H. Holbrook, Gaya S. Dasanayake, Duoyi Hu, Eden E. L. Tanner, Amanda B. Hummon, Davita L. Watkins. Uptake of Self-Assembling Amphiphilic Tryptophan-Based Polymer Nanoparticles in Three-Dimensional Cell Culture Models. ACS Applied Nano Materials 2024; 7(17) doi: 10.1021/acsanm.4c04589
|
| 264 |
Hem N. Naik, Dilip Kanjariya, Shahnaz Parveen, Iqrar Ahmed, Abha Meena, Harun Patel, Ramavatar Meena, Smita Jauhari. LC–MS profiling, in vitro and in silico C-ABL kinase inhibitory approach to identify potential anticancer agents from Dalbergia sissoo leaves. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-49995-1
|
| 265 |
Christian Marx, Jürgen Sonnemann, Oliver D. K. Maddocks, Lisa Marx-Blümel, Mandy Beyer, Doerte Hoelzer, René Thierbach, Claudia Maletzki, Michael Linnebacher, Thorsten Heinzel, Oliver H. Krämer. Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress. Cancer & Metabolism 2022; 10(1) doi: 10.1186/s40170-022-00286-9
|
| 266 |
Tetsuya Hamaguchi, Akihito Tsuji, Kensei Yamaguchi, Koji Takeda, Hiroyuki Uetake, Taito Esaki, Kenji Amagai, Daisuke Sakai, Hideo Baba, Masami Kimura, Yasuhiro Matsumura, Tetsuji Tsukamoto. A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients. Cancer Chemotherapy and Pharmacology 2018; 82(6) doi: 10.1007/s00280-018-3693-6
|
| 267 |
Marina Petković, Melad Henis, Oliver Heese, Angela Relógio. Chronotherapy in Glioblastoma: state of the art and future perspectives. eBioMedicine 2023; 89 doi: 10.1016/j.ebiom.2023.104470
|
| 268 |
Silvia R. Vitale, Melissa Drago, Federica Martorana, Chiara Conti, Michele Massimino, Stefania Stella, Cristina Tomarchio, Paolo Vigneri, Livia Manzella. Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review. Pharmaceutics 2026; 18(8) doi: 10.3390/pharmaceutics18080928
|
| 269 |
Oishi Mukherjee, Sudeshna Rakshit, Geetha Shanmugam, Koustav Sarkar. Role of chemotherapeutic drugs in immunomodulation of cancer. Current Research in Immunology 2023; 4 doi: 10.1016/j.crimmu.2023.100068
|
| 270 |
Christine M. Heske, Arnulfo Mendoza, Leah D. Edessa, Joshua T. Baumgart, Sunmin Lee, Jane Trepel, David A. Proia, Len Neckers, Lee J. Helman. STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma. Oncotarget 2016; 7(40) doi: 10.18632/oncotarget.11869
|
| 271 |
Bei Cheng, Peisheng Xu. Drug Repurposing in Cancer Therapy. 2020; doi: 10.1016/B978-0-12-819668-7.00013-0
|
| 272 |
Sanowar Hossain, Muhammad Yousaf, Yang Liu, Dennis Chang, Xian Zhou. An Overview of the Evidence and Mechanism of Drug–Herb Interactions Between Propolis and Pharmaceutical Drugs. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.876183
|
| 273 |
Roberto Puleio, Mariano Licciardi, Paola Varvarà, Cinzia Scialabba, Giovanni Cassata, Luca Cicero, Gennara Cavallaro, Gaetano Giammona. Effect of actively targeted copolymer coating on solid tumors eradication by gold nanorods-induced hyperthermia. International Journal of Pharmaceutics 2020; 587 doi: 10.1016/j.ijpharm.2020.119641
|
| 274 |
Aleksandra Sochacka-Ćwikła, Marcin Mączyński, Andrzej Regiec. FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021. Molecules 2022; 27(7) doi: 10.3390/molecules27072259
|
| 275 |
Anjaneyulu Patamsetti, Kumar Shiva Gubbiyappa. Enhancement of irinotecan oral bioavailability through quality by design approach in nanobubble formulation development. Brazilian Journal of Pharmaceutical Sciences 2026; 62 doi: 10.1590/s2175-97902026e24587
|
| 276 |
Debojyoti Adak, Priyanka Ray, Saini Setua. Unlocking therapeutic precision: “Camptotheca acuminata, a traditional chinese herb tailored for phytonano-cancer theranostics”. Pharmacological Research - Modern Chinese Medicine 2024; 11 doi: 10.1016/j.prmcm.2024.100447
|
| 277 |
Samreen Zaheer. Human Microbiome and their Implications for Oncological Diagnosis and Treatment. 2026; doi: 10.1016/B978-0-443-40551-8.00007-X
|
| 278 |
Anthony Dobi, Philippe Gasque, Pascale Guiraud, Jimmy Selambarom. Irinotecan (CPT-11) Canonical Anti-Cancer Drug Can also Modulate Antiviral and Pro-Inflammatory Responses of Primary Human Synovial Fibroblasts. Cells 2021; 10(6) doi: 10.3390/cells10061431
|
| 279 |
Dipanjan Ghosh, Gouranga Dutta, Arindam Chatterjee, Abimanyu Sugumaran, Gopal Chakrabarti, Sivakumar Manickam. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; doi: 10.1016/B978-0-443-19142-8.00005-X
|
| 280 |
Chunlei Xu, Xushan Tang, Yanli Qu, Saifuding Keyoumu, Ning Zhou, Yong Tang. UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer. Cancer Chemotherapy and Pharmacology 2016; 78(1) doi: 10.1007/s00280-016-3057-z
|
| 281 |
Yihan Wu, Di Wang, Xiaoqin Yang, Chaomei Fu, Liang Zou, Jinming Zhang. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice. Biomedicine & Pharmacotherapy 2019; 109 doi: 10.1016/j.biopha.2018.11.095
|
| 282 |
Beata Naumczuk, Marcin Górecki, Katarzyna Wiktorska, Magdalena Urbanowicz, Jerzy Sitkowski, Katarzyna Lubelska, Małgorzata Milczarek, Elżbieta Bednarek, Wojciech Bocian, Lech Kozerski. New camptothecin derivatives for generalized oncological chemotherapy: Synthesis, stereochemistry and biology. Bioorganic & Medicinal Chemistry Letters 2021; 46 doi: 10.1016/j.bmcl.2021.128146
|
| 283 |
Livia Ramos Santiago, Estéfani Alves Asevedo, Maria Eduarda Jeunon de Oliveira, Karen Cota Pereira, Maria Fernanda da Silva Trindade, Ana Gabriela Silva Oliveira, Marina Andrade Rocha, Sojin Kang, Amama Rani, Moon Nyeo Park, Michel William Tan, Rony Abdi Syahputra, Bonglee Kim, Rosy Iara Maciel de Azambuja Ribeiro. Artificial intelligence-based screening of phytochemicals for targeted cancer therapy. Natural Products and Bioprospecting 2026; 16(1) doi: 10.1007/s13659-026-00599-y
|
| 284 |
Danjun Wu, Yi Li, Lixi Zhu, Wangyang Zhang, Shumin Xu, Yan Yang, Qinying Yan, Gensheng Yang. A biocompatible superparamagnetic chitosan-based nanoplatform enabling targeted SN-38 delivery for colorectal cancer therapy. Carbohydrate Polymers 2021; 274 doi: 10.1016/j.carbpol.2021.118641
|
| 285 |
Ming-Hsien Lin, Chi-Feng Hung, Ching-Yun Hsu, Zih-Chan Lin, Jia-You Fang. Prodrugs in Combination with Nanocarriers as a Strategy for Promoting Antitumoral Efficiency. Future Medicinal Chemistry 2019; 11(16) doi: 10.4155/fmc-2018-0388
|
| 286 |
Abdullah S. Alhamed, Mohammed Alqinyah, Adel F. Alghaith, Mohammad M. Algahtani, Faleh Alqahtani, Fahd A. Nasr, Ali S. Alqahtani, Omar M. Noman, Abdulrahman S. Bazaid, Reem Hussain AlMalki, Anas M. Abdel Rahman, Khalid Alhazzani, Ahmed Z. Alanazi. Phytochemical analysis and anticancer activity of the Pithecellobium dulce seed extract in colorectal cancer cells. Open Chemistry 2023; 21(1) doi: 10.1515/chem-2023-0362
|
| 287 |
Can‐Can Zheng, Long Liao, Ya‐Ping Liu, Yan‐Ming Yang, Yan He, Guo‐Geng Zhang, Shu‐Jun Li, Ting Liu, Wen Wen Xu, Bin Li. Blockade of Nuclear β‐Catenin Signaling via Direct Targeting of RanBP3 with NU2058 Induces Cell Senescence to Suppress Colorectal Tumorigenesis. Advanced Science 2022; 9(34) doi: 10.1002/advs.202202528
|
| 288 |
Feiyu Chen, Zhangfeng Zhong, Cheng Zhang, Yuanjun Lu, Yau-Tuen Chan, Ning Wang, Di Zhao, Yibin Feng. Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine. International Journal of Molecular Sciences 2022; 23(21) doi: 10.3390/ijms232113334
|
| 289 |
Jatin Rawat, Ravikumar Kachhadiya, Hetal Thakkar. Comparative in-vitro and in-vivo evaluation of spherulites and cubosomes of Irinotecan for lung targeting. Therapeutic Delivery 2025; 16(4) doi: 10.1080/20415990.2025.2460421
|
| 290 |
Sofie Østergård Bæk, Kristina Keuper, Giacomo Milletti, Alba Adelantado-Rubio, Michael Lisby, Jiri Bartek, Christoffel Dinant, Apolinar Maya-Mendoza. Stepwise DNA damage and repair mechanisms at replication forks in response to topoisomerase I inhibition. DNA Repair 2026; 157 doi: 10.1016/j.dnarep.2025.103914
|
| 291 |
Daniel C. Pan, Vinu Krishnan, Alyssa K. Salinas, Jayoung Kim, Tao Sun, Sagi Ravid, Kevin Peng, Debra Wu, Md Nurunnabi, Jeffery A. Nelson, Zachary Niziolek, Junling Guo, Samir Mitragotri. Hyaluronic acid–doxorubicin nanoparticles for targeted treatment of colorectal cancer. Bioengineering & Translational Medicine 2021; 6(1) doi: 10.1002/btm2.10166
|
| 292 |
Mizuho Uneyama, James K. Chambers, Tadashi Fujii, Ko Nakashima, Kazuyuki Uchida. Establishment and characterization of a novel cell line and xenotransplant mouse model derived from feline colorectal adenocarcinoma. Veterinary Pathology 2024; 61(2) doi: 10.1177/03009858231189858
|
| 293 |
Ryosuke Negoro, Naoki Yamada, Keita Watanabe, Yusuke Kono, Takuya Fujita. Generation of Caco-2 cells stably expressing CYP3A4·POR·UGT1A1 and CYP3A4·POR·UGT1A1*6 using a PITCh system. Archives of Toxicology 2022; 96(2) doi: 10.1007/s00204-021-03175-0
|
| 294 |
Duygu Aydemir, Nuriye Nuray Ulusu. Pathophysiology of Cancer: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2024; 22 doi: 10.1007/16833_2024_219
|
| 295 |
Mercedes Lozano-García, Emre Dikici, Daniel Bilbao, Prasoon Mohan, Sapna Deo, Sylvia Daunert. Multifunctional delivery strategies and nanoplatforms of SN-38 in cancer therapeutics. Journal of Controlled Release 2025; 384 doi: 10.1016/j.jconrel.2025.113937
|
| 296 |
Jia Cui, Ziyi Zhang, Han Zhong, Tao Zhang. Phosphorylcholine-grafted graphene oxide loaded with irinotecan for potential oncology therapy. RSC Advances 2023; 13(41) doi: 10.1039/D3RA04987F
|
| 297 |
. 2022; doi: 10.70675/b590f7a1z8d32z47f3z9e73z7f97a6ac7736
|